Ebola vaccine trial launches in Sierra Leone
The study will determine the safety and effectiveness of the rVSV-ZEBOV Ebola vaccine against the virus that has had a devastating impact on West Africa. Health professionals are seeking to prevent similar outbreaks in the future, and producing a vaccine could be instrumental to addressing the global health concern.
"A safe and effective vaccine would be a very important tool to stop Ebola in the future and the frontline workers who are volunteering to participate are making a decision that could benefit health care professionals and communities wherever Ebola is a risk," Centers for Disease Control and Prevention (CDC) Director Tom Friden said. "We hope this vaccine will be proven effective but in the meantime we must continue doing everything necessary to stop this epidemic — find every case isolate and treat safely and respectfully bury the dead and find every single contact."
The trial is the results of a partnership between the CDC, the Sierra Leone Ministry of Health and Sanitation (MoHS) and the Sierra Leone College of Medicine and Allied Health Sciences (COMAHS).
"We are happy to be partnering with MoHS and CDC on this important study which may help to prevent future cases of Ebola," acting provost of COMAHS Mohamed Samai and the study's principal investigator said. "It brings me hope and pride that my country can take from this devastating epidemic something that may benefit people around the world."